An interventional study of TH-001 in PreDiabetes, sponsored by Tesu Saglik Teknolojileri A.S.. Completed at 1 site in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-01-10.
Sponsored by Tesu Saglik Teknolojileri A.S. · Not applicable, Interventional, and Treatment
The study aims to evaluate the efficacy and safety of a digital therapeutic (TH-001) for adult individuals with prediabetes.
999 studies on the registry are indexed under Prediabetic State; 238 are open to participants now.
This study's enrollment of 68 is close to the median of 65 across 844 interventional studies indexed under Prediabetic State.
Browse Prediabetic State studies →This is the only study on the registry with Tesu Saglik Teknolojileri A.S. as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Device: TH-001
TH001 is a software program intended to treat adults with prediabetes.
Change in HbA1c
The difference in the mean change from baseline in HbA1c (%) at Day 90 between groups.
Time frame: 90 days
Change in FPG
The difference in the mean change from baseline in FPG (mg/dL) at Day 90 between groups.
Time frame: 90 days
Change in PPG
The difference in the mean change from baseline in 2-hour 75 g OGTT (mg/dL) at Day 90 between groups.
Time frame: 90 days
Change in weight
The difference in the mean change from baseline in weight (kg) at Day 90 between groups.
Time frame: 90 days
Change in BMI
The difference in the mean change from baseline in BMI (kg/m\^2) at Day 90 between groups.
Time frame: 90 days
Change in WC
The difference in the mean change from baseline in Waist Circumference (centimeters) at Day 90 between groups.
Time frame: 90 days
Change in WHR
The difference in the mean change from baseline in waist-to-hip ratio (WHR) (waist circumference and hip circumference measured in centimeters) at Day 90 between groups.
Time frame: 90 days
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.